A5030963021- Venous Thromboembolism Diagnosis and Management
- Central Venous Catheters and Hemodialysis
- Atrial Fibrillation Management and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Systemic Sclerosis and Related Diseases
- Economic and Financial Impacts of Cancer
- Pulmonary Hypertension Research and Treatments
- Healthcare Systems and Practices
- Cardiac tumors and thrombi
- Acute Myocardial Infarction Research
- Diagnosis and Treatment of Venous Diseases
- Vascular Procedures and Complications
- Hepatocellular Carcinoma Treatment and Prognosis
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Sepsis Diagnosis and Treatment
- Parathyroid Disorders and Treatments
- Body Image and Dysmorphia Studies
- Cardiac Imaging and Diagnostics
- Ultrasound in Clinical Applications
- Lymphoma Diagnosis and Treatment
- COVID-19 and healthcare impacts
- Intramuscular injections and effects
- Acute Ischemic Stroke Management
- Autoimmune Bullous Skin Diseases
Jewish General Hospital
2023
McGill University
2023
Martin University Hospital
2023
Assistance Publique – Hôpitaux de Paris
2018-2021
Hôpital Saint-Louis
2017-2021
Groupe Francophone des Myélodysplasies
2021
Recherche clinique appliquée à l'hématologie
2020
Université Paris Cité
2018
Centre Hospitalier Universitaire de Martinique
2018
Délégation Paris 7
2018
Contagious disease outbreaks and related restrictions can lead to negative psychological outcomes, particularly in vulnerable populations at risk due pre-existing medical conditions. No randomised controlled trials (RCTs) have tested interventions reduce mental health consequences of contagious outbreaks. The primary objective the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Trial is evaluate effect a videoconference-based program...
To assess the reproducibility and utility of 6-minute walk test (6MWT) in systemic sclerosis (SSc).All patients with SSc who underwent at least two 6MWT within a minimum 3-month interval plus simultaneous routine clinical, biological, functional evaluations were consecutively enrolled this observational study over 6 years. Following American Thoracic Society guidelines, each was repeated twice to distance (6MWD) reproducibility, highest value being reported for subsequent analysis.Among 56...
Clinical guidelines recommend at least 3-months low molecular weight heparin (LMWH) treatment for established venous thromboembolism (VTE) in cancer patients. However, no study has analyzed the impact of 3-6 months LMWH therapy on quality-of-life (QoL) patients.Among 400 patients included M0, 88.8% received long-term LMWH. Using a random-effects linear regression model with time as covariate, QoL scores MOS SF-36 (Global HRQoL, 1.3-fold per month [95% confidence interval (CI) 0.81-1.79], p <...
Heparin-induced thrombocytopenia with thrombosis (HITT) is a rare immune reaction to the drug heparin that causes increased blood clotting, putting patients at risk for arterial and venous thromboembolism which can have severe consequences. We present case of HITT successfully treated direct oral anticoagulant (DOAC), edoxaban. A 56-year-old man had surgery remove colorectal mass. After discharge, he developed chest discomfort, shortness breath, low oxygen levels was diagnosed right-sided...
<h3>Background</h3> Venous thromboembolism (VTE), including deep-vein thrombosis (DVT) and pulmonary embolism (PE), is a frequent severe complication in cancer patients, which the second leading cause of death this population. International guidelines recommend low-molecular weight heparin (LMWH)-based treatment during at least 3 months until chemotherapy begins. The pharmacy internal medicine department have developed patient education programme (PEP) dedicated to patients treated for...
Background: Direct oral anticoagulants (DOAC) have shown an upward prescribing trend in recent years due to favorable pharmacokinetics and pharmacodynamics without requirement for routine coagulation monitoring.However, studies documented inter-individual variability plasma drug levels.Aims: The purpose of our study is investigate the effects CYP2J2, CYP3A5 CYP3A4 gene polymorphisms on DOAC levels.Methods: local Ethical Committee approved this study.For selection tag single nucleotide...